VWM
NBP

Vermillion Wealth Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Vermillion Wealth Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$492 – 1970
2026
Q1 		$492 Hold
200
– – ﹤0.01% 1022
2025
Q4 		$796 Buy
+200
New +$885 ﹤0.01% 558
2025
Q2 		– Sell
-200
Closed -$165 – 558
2025
Q1 		$165 Hold
200
– – ﹤0.01% 1287
2024
Q4 		$170 Buy
+200
New +$223 ﹤0.01% 527

Other funds holding NBP

AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Vermillion Wealth Management's NBP Position: Q2 2026 in Review

Vermillion Wealth Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 200 shares — an estimated $492 sold.

Vermillion Wealth Management first reported a position in NBP in Q4 2024 and held it in 4 quarters. The position peaked at $796 in Q4 2025. 6 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Vermillion Wealth Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 200 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $492.
  • Vermillion Wealth Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2024 and held it in 4 quarters.
  • Vermillion Wealth Management's NovaBridge Biosciences American Depositary Shares position peaked at $796 in Q4 2025.
  • 6 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.